The CYP24A1 gene helps your body switch off extra active vitamin D, which keeps calcium levels in balance. If it does not work properly, active vitamin D can stay too high and calcium may build up in the blood or urine. This can lead to symptoms such as vomiting, poor feeding, thirst, dehydration, or kidney stones, and some people may develop kidney problems over time. Some are diagnosed in infancy, while others are identified later after repeated high calcium levels or stones.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which do much of the cell’s work. Others are mainly involved in controlling when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you react to food, stress, or medicines. To go further into this subject, you can read more in LearnHub.
Overview
CYP24A1Gene function
What if the gene works
The CYP24A1 gene helps break down active vitamin D when your body has enough. This supports healthy calcium balance in the blood and helps protect the kidneys and other tissues from buildup.
Risk
What if the gene does not work
Reduced activity of the CYP24A1 gene can slow vitamin D breakdown and raise calcium in blood and urine. Milder to more severe variants may cause high blood calcium, kidney stones, or calcium buildup in the kidneys, from infancy to adulthood.
Treatment
What does that mean for your treatment
Pathogenic variants in the CYP24A1 gene change treatment because vitamin D supplements, calcitriol, and often high calcium intake can worsen high calcium levels and kidney problems, so they are usually avoided. Care often centers on hydration and other calcium lowering measures, and some people may benefit from medicines such as fluconazole or rifampin that help reduce active vitamin D levels.
Conditions associated with CYP24A1
Gene function
What if the gene works
Your body needs vitamin D, but it also needs to keep vitamin D activity within a healthy range. The CYP24A1 gene helps with that balance by making an enzyme that breaks down used or extra active vitamin D. This steady cleanup supports normal calcium handling and everyday bone and mineral health.
The CYP24A1 gene makes an enzyme that breaks down active forms of vitamin D after they have done their job. This is one way the CYP24A1 gene helps control vitamin D levels in the body.
By lowering extra vitamin D activity, this gene helps keep the signal from lasting longer than needed. That gives your body a more controlled response to vitamin D from sunlight, food, and supplements.
This gene supports healthy calcium and phosphate balance by helping set the pace of vitamin D action. That steady control supports normal bone mineralization and helps muscles and nerves work within their usual range.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help account for normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CYP24A1 gene can alter the enzyme's shape, stability, or length, so CYP24A1 gene variants can reduce vitamin D breakdown inside cells. Some variants leave partial activity, while more severe variants can nearly stop the enzyme from working, leading to a larger buildup of calcium-raising vitamin D signals. This range of functional effects helps explain why infantile hypercalcemia may appear earlier or be more marked in some people than in others.
How variants are linked to conditions
Pathogenic variants in the CYP24A1 gene can cause infantile hypercalcemia type 1, a condition with high calcium levels that may lead to poor feeding, vomiting, kidney stones, or calcium buildup in the kidneys. In older children and adults, CYP24A1-related hypercalcemia can also appear as recurrent kidney stones or high calcium in the urine. Some people carrying one variant may have milder findings, but the strongest gene-condition link is when both copies are affected.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than confirming that condition, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
For people with disease-causing changes in the CYP24A1 gene, risk is shaped less by lifestyle and more by the gene change itself. Episodes of high calcium can be more likely or more severe with vitamin D supplements, calcium supplements, strong sun exposure, dehydration, and sometimes during pregnancy. Careful monitoring helps lower the chance of kidney stones and kidney damage.
Inheritance of CYP24A1 variants
CYP24A1-related conditions are usually inherited in an autosomal recessive pattern. This means a child needs to inherit two altered copies of the CYP24A1 gene, one from each parent, to have the condition. If both parents carry one CYP24A1 variant, each pregnancy has a 25% chance of the child inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. This is the main answer to how variants of the CYP24A1 gene are inherited in families.
What does my CYP24A1 result mean for my family?
For families with a CYP24A1-related condition, the pattern is usually recessive, which means close relatives may be carriers even if they have never had symptoms. Brothers and sisters could also have the condition or carry the same gene change. For many families, this means parents, siblings, and sometimes adult children may want to learn whether they carry the same result.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CYP24A1 variants usually uses a blood or saliva sample. A lab reads the CYP24A1 gene to look for variants, and results are often reported as pathogenic, likely pathogenic, benign, or of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the CYP24A1 gene may be worth considering if you or your child has repeated high calcium levels, kidney stones, or calcium buildup in the kidneys, especially after taking vitamin D. It can also help when these problems run in the family or started in infancy.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it tells you depends on the condition and the specific type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body works. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small inherited differences can change how the body breaks down a drug, moves it into tissues, or responds to it at its target. This helps explain why the same treatment may work well for one person, have less effect in another, or cause stronger side effects in someone else. These differences are common and are one part of why medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It looks at gene-drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This understanding can support more informed and more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the CYP24A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice, so general questions about medicines or new symptoms are best discussed with your doctor. CYP24A1 has been studied because changes in it can affect how the body breaks down vitamin D, so medical advice is especially important if vitamin D supplements seem to be linked with high calcium symptoms such as thirst, nausea, or kidney stones.
History
The CYP24A1 gene entered medical genetics through research on vitamin D in the late 20th century, when scientists were mapping the enzymes that control calcium balance. In recent decades, awareness of this gene’s role has grown as researchers linked it to inherited forms of infantile hypercalcemia, a condition marked by high calcium levels in babies. That discovery helped explain older case reports of infants who became unwell after routine vitamin D exposure. Building on this early work, scientists uncovered more about the CYP24A1 gene through family studies and modern DNA testing. Its identification marked an important step in connecting unusual calcium problems with a specific inherited cause. Today, the gene is part of established evaluation for some unexplained calcium and kidney stone patterns.